Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.32 USD | +0.87% | -0.43% | +0.43% |
05-15 | Compugen Names David Silberman CFO | MT |
05-09 | Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.43% | 94.26M | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+45.43% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- ORMP Stock
- News Oramed Pharmaceuticals Inc.
- Oramed Pharmaceuticals Reports Additional Positive Mid-Stage Data for Oral Insulin Candidate